Release from Memphis Pharmaceuticals (MPCI.CA) Regarding the Board of Directors' Decisions
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
Referring to what was published on the trading screens on 15/03/2022, concerning the Board of Directors' decisions held on 14/03/2022, the company sent a supplementary release regarding borrowing from Abu Dhabi Bank.
The Release (54 KB)
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
Referring to what was published on the trading screens on 15/03/2022, concerning the Board of Directors' decisions held on 14/03/2022, the company sent a supplementary release regarding borrowing from Abu Dhabi Bank.
The Release (54 KB)
Comments